Please login to the form below

TWO SENIOR APPOINTMENTS FOR CELLO HEALTH BIOCONSULTING

Cello Health BioConsulting, the newly-formed strategic management consulting firm focusing on pharmaceuticals, biotechnology and medical device companies in the United States, has announced the appointment of Philip Vorhies and Mark Kasakevich as Vice-Presidents.


Philip Vorhies is an experienced strategy and operations executive with over 15 years of biopharmaceutical industry experience, both in the industry at Pharmacia/Pfizer in a variety of roles, and in global consulting at Campbell Alliance, focused on commercial strategy and asset value maximization.  He has particular experience in brand and portfolio strategy, life cycle planning, launch strategy and planning, forecasting and competitive gaming.
 

Mark Kasakevich has over 20 years experience in healthcare and consulting at Bayer, IMS Health and Campbell Alliance.  He has extensive experience in forming, facilitating and leading cross-functional teams. His expertise is in strategic planning, product launch, operational improvements and competitive preparedness.
 

Julia Ralston, CEO of Cello Health US, commented, “We are delighted to welcome two very senior and experienced practitioners into the Cello Health BioConsulting team.  Both Philip and Mark bring wide-ranging disease area knowledge and experience, as well as extensive commercial and launch strategy and operations expertise.”
  “These appointments strengthen Cello Health’s global strategy of establishing itself as one of a small number of high quality, technically led advisers to the pharmaceutical and healthcare sectors”  

Philip and Mark will be based at Cello Health’s BioConsulting Philadelphia office.  

                                                                                    - ends -  

Cello Health
  Cello Health consists of three distinct capabilities:
  • Cello Health Insight: global marketing research and customer insight
  • Cello Health Consulting: strategic consultancy
  • Cello Health Communications: evidence and engagement
For further media information, please contact: Helen Lawn on +44 (0)1892 525141 or +44 (0)7879 818247, helen@helenlawn.co.uk; or Andy Newman on +44 (0)1603 465636 or +44 (0)7739 847964, andy@newmanassociates.co.uk

23rd July 2015

Share

Company Details

Cello Health

+44 (0)20 7812 8460

Contact Website

Address:
11-13 Charterhouse Buildings
London
EC1M 7AP
UK

Latest content on this profile

Cello Health Acquire ISS
Acquisition further strengthens technical advisory services in US
Cello Health
Cello Health launches ‘Cello Health GmbH’ with new Berlin office and appointment of two regional directors to lead the Business Insights and Analytics division in Germany.
London, July 08, 2019 Cello Health GmbH opens in Berlin with its Business Insights and Analytics division, Cello Health Insight, appointing two regional directors: Heike Tombrink – Regional Director, Head of Cello Health Insight Germany, and Matthias Heurich – Regional Director, supporting Digital Innovation.
Cello Health
Cello Health Insight wins EphMRA’s 2019 Market Research Excellence Award for 'Business Impact through Innovation'
Cello Health Insight in partnership with Janssen Pharmaceuticals has won EphMRA’s 2019 Market Research Excellence Award for 'Business Impact through Innovation'.
Cello Health
Cello Health Launches New Social Insight & Analytics Business
Cello Health Logic offers pharmaceutical companies the ability to make sense of healthcare social media conversations and deliver actionable insights.
Cello Health
Managing value: Why early asset development and commercialization is important
Realising the full value of your asset – clinically and commercially – means thinking beyond the pure scientific value, even at the very early stages of development.
Cello Health
Optimising market research data in rare disease
Helping to provide powerful insights into the burden of disease and the patient-caregiver experience.
Cello Health